The Technical AnalystExchange: SHZ Sector: Basic Materials Industry: Chemicals
Yantai Dongcheng Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% CNY13.83
America/New_York / 30 apr 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 11 404 mill |
| EPS: | 0.270 |
| P/E: | 51.22 |
| Earnings Date: | May 17, 2024 |
| SharesOutstanding: | 824.60 mill |
| Avg Daily Volume: | 10.37 mill |
| RATING 2024-04-30 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.09x |
| Company: PE 51.22 | sector: PE 46.94 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.52x |
| Company: PE 51.22 | industry: PE 33.80 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY15.43 (11.53%) CNY1.595 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 13.24 - 14.42 ( +/- 4.24%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY13.83 (0.00% ) |
| Volume | 10.30 mill |
| Avg. Vol. | 10.37 mill |
| % of Avg. Vol | 99.34 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002675.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002675.SZ
Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical API, chemical medicines, proprietary Chinese medicines, and nuclide drugs products in China. It offers heparin, chondroitin sulphate, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C for use in the therapeutic areas of cardiovascular, oncology, urology, orthopedics, and other therapeutic areas. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.